95 related articles for article (PubMed ID: 6204735)
1. Elevated concentrations of substance P and 5-HT in plasma in patients with carcinoid tumors.
Emson PC; Gilbert RF; Martensson H; Nobin A
Cancer; 1984 Aug; 54(4):715-8. PubMed ID: 6204735
[TBL] [Abstract][Full Text] [Related]
2. Substance P in the localization of a carcinoid tumor.
Strodel WE; Vinik AI; Jaffe BM; Eckhauser FE; Thompson NW
J Surg Oncol; 1984 Oct; 27(2):106-11. PubMed ID: 6207386
[TBL] [Abstract][Full Text] [Related]
3. Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors.
Feldman JM; O'Dorisio TM
Am J Med; 1986 Dec; 81(6B):41-8. PubMed ID: 2432780
[TBL] [Abstract][Full Text] [Related]
4. Chemical and immunochemical characterisation of substance P-like immunoreactivity and physalaemin-like immunoreactivity in a carcinoid tumour.
Conlon JM; Schäfer G; Schmidt WE; Lazarus LH; Becker HD; Creutzfeldt W
Regul Pept; 1985 Jun; 11(2):117-32. PubMed ID: 2412263
[TBL] [Abstract][Full Text] [Related]
5. Pancreastatin-like immunoreactivity in human carcinoid disease.
McGrath-Linden SJ; Johnston CF; O'Connor DT; Shaw C; Buchanan KD
Regul Pept; 1991 Mar; 33(1):55-70. PubMed ID: 2047545
[TBL] [Abstract][Full Text] [Related]
6. The pentagastrin test in the diagnosis of the carcinoid syndrome. Blockade of gastrointestinal symptoms by ketanserin.
Ahlman H; Dahlström A; Grönstad K; Tisell LE; Oberg K; Zinner MJ; Jaffe BM
Ann Surg; 1985 Jan; 201(1):81-6. PubMed ID: 2578277
[TBL] [Abstract][Full Text] [Related]
7. Plasma substance-P in neuroendocrine tumors and idiopathic flushing: the value of pentagastrin stimulation tests and the effects of somatostatin analog.
Vinik AI; Gonin J; England BG; Jackson T; McLeod MK; Cho K
J Clin Endocrinol Metab; 1990 Jun; 70(6):1702-9. PubMed ID: 1693375
[TBL] [Abstract][Full Text] [Related]
8. Tachykinins in carcinoid tumors: their use as a tumor marker and possible role in the carcinoid flush.
Norheim I; Theodorsson-Norheim E; Brodin E; Oberg K
J Clin Endocrinol Metab; 1986 Sep; 63(3):605-12. PubMed ID: 2426299
[TBL] [Abstract][Full Text] [Related]
9. Serum prostaglandin F-2 alpha concentration in the carcinoid syndrome.
Feldman JM; Plonk JW; Cornette JC
Prostaglandins; 1974 Sep; 7(6):501-6. PubMed ID: 4278267
[No Abstract] [Full Text] [Related]
10. Serotonin metabolism in patients with carcinoid tumors: incidence of 5-hydroxytryptophan-secreting tumors.
Feldman JM
Gastroenterology; 1978 Dec; 75(6):1109-14. PubMed ID: 309417
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of whole blood serotonin and plasma and urine 5-hydroxyindole acetic acid in diagnosis of carcinoid disease.
Carling RS; Degg TJ; Allen KR; Bax ND; Barth JH
Ann Clin Biochem; 2002 Nov; 39(Pt 6):577-82. PubMed ID: 12564839
[TBL] [Abstract][Full Text] [Related]
12. Expression of tachykinins by ileal and lung carcinoid tumors assessed by combined in situ hybridization, immunocytochemistry, and radioimmunoassay.
Bishop AE; Hamid QA; Adams C; Bretherton-Watt D; Jones PM; Denny P; Stamp GW; Hurt RL; Grimelius L; Harmar AJ
Cancer; 1989 Mar; 63(6):1129-37. PubMed ID: 2645037
[TBL] [Abstract][Full Text] [Related]
13. The effect of carcinoid levels of serotonin and substance P on hemodynamics.
Zinner MJ; Yeo CJ; Jaffe BM
Ann Surg; 1984 Feb; 199(2):197-204. PubMed ID: 6198979
[TBL] [Abstract][Full Text] [Related]
14. Substance P in ovarian carcinoid.
Skrabanek P; Dervan P; Cannon D; Powell D
J Clin Pathol; 1980 Feb; 33(2):160-2. PubMed ID: 6154065
[TBL] [Abstract][Full Text] [Related]
15. High serum levels of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in patients with carcinoid tumors.
Klootwijk W; de Herder WW; Kwekkeboom DJ; Lamberts SW; Krenning EP; Visser TJ; de Greef WJ
J Clin Endocrinol Metab; 1996 Aug; 81(8):2816-20. PubMed ID: 8768836
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide K: a major tachykinin in plasma and tumor tissues from carcinoid patients.
Theodorsson-Norheim E; Norheim I; Oberg K; Brodin E; Lundberg JM; Tatemoto K; Lindgren PG
Biochem Biophys Res Commun; 1985 Aug; 131(1):77-83. PubMed ID: 2412557
[TBL] [Abstract][Full Text] [Related]
17. Carcinoid tumors of the pancreas. Status report based on two cases and review of the world's literature.
Mao C; el Attar A; Domenico DR; Kim K; Howard JM
Int J Pancreatol; 1998 Apr; 23(2):153-64. PubMed ID: 9629513
[TBL] [Abstract][Full Text] [Related]
18. Substance P and enteroglucagon-like immunoreactivity in argentaffin and argyrophil midgut carcinoid tumours.
Wilander E; Grimelius L; Portela-Gomes G; Lundqvist G; Skoog V; Westermark P
Scand J Gastroenterol Suppl; 1979; 53():19-25. PubMed ID: 384502
[TBL] [Abstract][Full Text] [Related]
19. Electron microscopical and biochemical studies on the serotonin granules in carcinoid syndrome.
May B; Bak IJ; Böhle E; Hassler R
Life Sci; 1968 Aug; 7(16):785-800. PubMed ID: 5672302
[No Abstract] [Full Text] [Related]
20. [Primary ovarian carcinoid with secretion of human pancreatic polypeptide and immunoreactivity to substance P].
Proye C; Lefebvre J; Lemaire C; Fontaine P; Dupire E; Verin P; Racadot-Leroy N; Lecomte-Houcke M; Chayvialle JA
Chirurgie; 1988; 114(3):234-43. PubMed ID: 2461840
[No Abstract] [Full Text] [Related]
[Next] [New Search]
